Nykode Therapeutics AS (OSL:NYKD)

Nykode Therapeutics AS Revenue

Nykode Therapeutics AS had revenue of $106.00K USD in the quarter ending June 30, 2026, a decrease of -46.46%. This brings the company's revenue in the last twelve months to $464.00K, down -20.68% year-over-year. In the year 2025, Nykode Therapeutics AS had annual revenue of $453.00K, down -95.05%.

• Revenue (ttm): $464.00K
• Revenue Growth: -20.68%
• P/S Ratio: 280.63
• Revenue / Employee: $7.86K
• Employees: 59
• Market Cap: 1.29B NOK

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	453.00K	-8.71M	-95.05%
Dec 31, 2024	9.16M	-4.17M	-31.26%
Dec 31, 2023	13.32M	4.29M	47.56%
Dec 31, 2022	9.03M	-26.74M	-74.76%
Dec 31, 2021	35.77M	-179.93M	-83.42%
Dec 31, 2020	215.70M	-1.22B	-85.01%
Dec 31, 2019	1.44B	24.09M	1.70%
Dec 31, 2018	1.41B	1.41B	118,836.18%
Dec 31, 2017	1.19M	147.46K	14.15%
Dec 31, 2016	1.04M	405.57K	63.74%
Dec 31, 2015	636.33K	-534.45K	-45.65%
Dec 31, 2014	1.17M	-	-

Data Source: Fiscal.ai Last updated: Aug 25, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error